A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study
Phase 4
- Conditions
- Acute myocardial infarctioncoronary artery thrombosis10011082
- Registration Number
- NL-OMON34112
- Lead Sponsor
- Catharina-ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1800
Inclusion Criteria
STEMI <12 hours (or STE equivalent), or NSTEMI <48 hours
No contraindication for PCI, abciximab, bivalirudin or clopidogrel
Informed consent from the patient
Exclusion Criteria
Contraindication for PCI, GPI, bivalirudin or clopidogrel
Thrombolytic therapy within the last 24 hours
Therapy with GPI within the last 24 hours
Anticoagulantion therapy
No Informed Consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method